Markets:

Overview

News

Currencies

International

Treasuries

Nkarta, Inc. - Common Stock (NQ:NKTX)

1.810 -0.080 (-4.23%)

Streaming Delayed Price Updated: 4:00 PM EST, Dec 1, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Nkarta, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >

Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030

January 09, 2024

EQNX::TICKER_START (NASDAQ:ONCY),(TSX:ONC),(NASDAQ:AMGN),(NASDAQ:AMAM),(NASDAQ:ELEV),(NASDAQ:NKTX) EQNX::TICKER_END

Via FinancialNewsMedia

Hewlett Packard Enterprise, Hologic And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

January 09, 2024

U.S. stock futures were lower this morning, with the Dow Jones futures falling around 100 points on Tuesday. Shares of Hewlett Packard Enterprise Company (NYSE: HPE) shares fell sharply in pre-market...

Via Benzinga

Topics Stocks

What's Going On With Cancer Drug-Developer Nkarta Stock? ↗

January 08, 2024

Nkarta, Inc. (NASDAQ: NKTX) shares are blasting higher Monday, and the stock has gained more than 270% over the past month. Here's a look at what's going on.

Via Benzinga

Analyst Ratings for Nkarta ↗

December 12, 2023

Via Benzinga

The Latest Analyst Ratings for Nkarta ↗

November 16, 2023

Via Benzinga

Analyst Expectations for Nkarta's Future ↗

October 18, 2023

Via Benzinga

The Latest Analyst Ratings for Nkarta ↗

August 10, 2023

Via Benzinga

Global Oncology Cancer Drugs Market Revenue Projected To Surpass $289 Billion By 2030

January 09, 2024

From FN Media Group LLC

Via GlobeNewswire

Dow Surges Over 100 Points; Commercial Metals Posts Upbeat Q1 Results ↗

January 08, 2024

U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 100 points on Monday. The Dow traded up 0.35% to 37,596.43 while the NASDAQ rose 1.89% to 14,799.21. The...

Via Benzinga

Topics Stocks

Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

January 08, 2024

Shares of RxSight, Inc. (NASDAQ: RXST) rose sharply during Monday’s session after the company issued preliminary FY23 and FY24 revenue guidance above estimates. Also, Needham maintained a Buy rating on...

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

January 08, 2024

Via Benzinga

Pinstripes, SoFi Technologies And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session ↗

January 03, 2024

U.S. stock futures were lower this morning, with the Dow Jones futures falling around 60 points on Wednesday. Shares of Pinstripes (NYSE: PNST) shares fell in pre-market trading after surging 22% on...

Via Benzinga

Topics Stocks

Nkarta Presents NKX101 Clinical Data at the 2023 American Society of Hematology Annual Meeting & Exposition

December 09, 2023

From Nkarta, Inc.

Via GlobeNewswire

Nkarta Reports Third Quarter 2023 Financial Results and Corporate Highlights

November 09, 2023

From Nkarta, Inc.

Via GlobeNewswire

These Biotech Stocks Could Double Your Money, According To Analysts ↗

November 09, 2023

Via Benzinga

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 19, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For October 18, 2023 ↗

October 18, 2023

Via Benzinga

Visa To Rally More Than 15%? Here Are 10 Top Analyst Forecasts For Wednesday ↗

October 18, 2023

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

Why ServisFirst Bancshares Shares Are Trading Lower By 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

October 17, 2023

Gainers SciSparc Ltd. (NASDAQ: SPRC) shares climbed 146.2% to $6.97. Aegis Capital Corp. acted as exclusive placement agent on a $5.0 million private placement for SciSparc.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

October 17, 2023

Via Benzinga

What's Going With Cancer-Focused Nkarta Stock Today? ↗

October 17, 2023

Nkarta Inc (NASDAQ: NKTX) received FDA clearance for its Investigational New Drug (IND) application to evaluate NKX019, its allogeneic, CD19-directed CAR NK cell therapy candidate,

Via Benzinga

Nkarta Receives FDA Clearance of IND Application for NKX019 in Lupus Nephritis

October 17, 2023

From Nkarta, Inc.

Via GlobeNewswire

Nkarta to Host Conference Call on Tuesday, October 17 at 8am ET to Discuss Expansion of Clinical Pipeline and Organizational Cost Measures

October 16, 2023

Call scheduled for Tuesday, October 17, 2023 at 8:00 a.m. ET

From Nkarta, Inc.

Via GlobeNewswire

3 Promising Biotech Stocks That Will Make Early Investors Rich ↗

October 02, 2023

Despite their volatility, certain biotech stocks stand out for their innovative approaches and potential game-changing therapies.

Via InvestorPlace

Stocks That Hit 52-Week Lows On Friday ↗

September 29, 2023

Friday's session saw 112 companies set new 52-week lows.

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

September 07, 2023

On Thursday, 283 companies set new 52-week lows.

Via Benzinga

Nkarta Reports Second Quarter 2023 Financial Results and Corporate Highlights

August 10, 2023

From Nkarta, Inc.

Via GlobeNewswire

3 Hidden Penny Stocks That Could Turn $100 into $10,000 ↗

July 31, 2023

These penny stocks have multibagger upside potential with great margins of safety, according to Wall Street analysts.

Via InvestorPlace

Stocks That Hit 52-Week Lows On Wednesday ↗

July 05, 2023

Wednesday's session saw 43 companies set new 52-week lows.

Via Benzinga

NKX101's Leukemia Setting Phase 1 Results a Setback for Nkarta: Analyst Lowers Price Target Amid Revised Development Timeline ↗

June 27, 2023

Nkarta Inc (NASDAQ: NKTX) announced updated data from the Phase 1 study of NKX101 to treat patients with relapsed or refractory (r/r)

Via Benzinga

< Previous 1 2 3 4 5 6 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.